Effective inhibition of cell growth and invasion of melanoma by combined suppression of BRAF (V599E) and Skp2 with lentiviral RNAi

Hidetoshi Sumimoto, Kenro Hirata, Shizuko Yamagata, Hiroyuki Miyoshi, Makoto Miyagishi, Kazunari Taira, Yutaka Kawakami

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

p27Kip1 that regulates the G1/S transition of cell cycle and inhibits Rho A signaling is frequently lost in several cancers leading to the deregulation of cell growth and cell motility. Mitogen-activated protein kinases (MAPK) regulate the export of p27Kip1 from nucleus to cytoplasm, followed by the degradation with proteases. Skp-2, a subunit of an SCF ubiquitin-protein ligase complex responsible for the ubiquitination of p27 Kip1, is upregulated frequently in several cancers, leading to the decrease of p27Kip1. We applied human immunodeficiency virus (HIV) lentivirus-mediated RNA interference (RNAi) to melanoma cells with the BRAF mutation (V599E) and overexpressed Skp-2 and found that the simultaneous suppression of these activated oncogenes resulted in the effective inhibition of in vitro cell growth and invasive ability of melanoma cells accompanied by the additional increase of p27Kip1. Our results suggest that gene therapy against melanoma with the enhanced MAPK and ubiquitin-proteasomal pathways could be a specific and effective therapeutic strategy for cancers.

Original languageEnglish
Pages (from-to)472-476
Number of pages5
JournalInternational Journal of Cancer
Volume118
Issue number2
DOIs
Publication statusPublished - 2006 Jan 15

Fingerprint

RNA Interference
Melanoma
Growth
Mitogen-Activated Protein Kinases
Ubiquitin-Protein Ligase Complexes
SKP Cullin F-Box Protein Ligases
Neoplasms
Lentivirus
Ubiquitination
Ubiquitin
Oncogenes
Genetic Therapy
Cell Movement
Cell Cycle
Cytoplasm
Peptide Hydrolases
HIV
Mutation
Therapeutics

Keywords

  • BRAF
  • lentivirus
  • p27
  • RNA interference
  • Skp-2

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Effective inhibition of cell growth and invasion of melanoma by combined suppression of BRAF (V599E) and Skp2 with lentiviral RNAi. / Sumimoto, Hidetoshi; Hirata, Kenro; Yamagata, Shizuko; Miyoshi, Hiroyuki; Miyagishi, Makoto; Taira, Kazunari; Kawakami, Yutaka.

In: International Journal of Cancer, Vol. 118, No. 2, 15.01.2006, p. 472-476.

Research output: Contribution to journalArticle

Sumimoto, Hidetoshi ; Hirata, Kenro ; Yamagata, Shizuko ; Miyoshi, Hiroyuki ; Miyagishi, Makoto ; Taira, Kazunari ; Kawakami, Yutaka. / Effective inhibition of cell growth and invasion of melanoma by combined suppression of BRAF (V599E) and Skp2 with lentiviral RNAi. In: International Journal of Cancer. 2006 ; Vol. 118, No. 2. pp. 472-476.
@article{1b6e76bb52864feba9a041da2738fb48,
title = "Effective inhibition of cell growth and invasion of melanoma by combined suppression of BRAF (V599E) and Skp2 with lentiviral RNAi",
abstract = "p27Kip1 that regulates the G1/S transition of cell cycle and inhibits Rho A signaling is frequently lost in several cancers leading to the deregulation of cell growth and cell motility. Mitogen-activated protein kinases (MAPK) regulate the export of p27Kip1 from nucleus to cytoplasm, followed by the degradation with proteases. Skp-2, a subunit of an SCF ubiquitin-protein ligase complex responsible for the ubiquitination of p27 Kip1, is upregulated frequently in several cancers, leading to the decrease of p27Kip1. We applied human immunodeficiency virus (HIV) lentivirus-mediated RNA interference (RNAi) to melanoma cells with the BRAF mutation (V599E) and overexpressed Skp-2 and found that the simultaneous suppression of these activated oncogenes resulted in the effective inhibition of in vitro cell growth and invasive ability of melanoma cells accompanied by the additional increase of p27Kip1. Our results suggest that gene therapy against melanoma with the enhanced MAPK and ubiquitin-proteasomal pathways could be a specific and effective therapeutic strategy for cancers.",
keywords = "BRAF, lentivirus, p27, RNA interference, Skp-2",
author = "Hidetoshi Sumimoto and Kenro Hirata and Shizuko Yamagata and Hiroyuki Miyoshi and Makoto Miyagishi and Kazunari Taira and Yutaka Kawakami",
year = "2006",
month = "1",
day = "15",
doi = "10.1002/ijc.21286",
language = "English",
volume = "118",
pages = "472--476",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Effective inhibition of cell growth and invasion of melanoma by combined suppression of BRAF (V599E) and Skp2 with lentiviral RNAi

AU - Sumimoto, Hidetoshi

AU - Hirata, Kenro

AU - Yamagata, Shizuko

AU - Miyoshi, Hiroyuki

AU - Miyagishi, Makoto

AU - Taira, Kazunari

AU - Kawakami, Yutaka

PY - 2006/1/15

Y1 - 2006/1/15

N2 - p27Kip1 that regulates the G1/S transition of cell cycle and inhibits Rho A signaling is frequently lost in several cancers leading to the deregulation of cell growth and cell motility. Mitogen-activated protein kinases (MAPK) regulate the export of p27Kip1 from nucleus to cytoplasm, followed by the degradation with proteases. Skp-2, a subunit of an SCF ubiquitin-protein ligase complex responsible for the ubiquitination of p27 Kip1, is upregulated frequently in several cancers, leading to the decrease of p27Kip1. We applied human immunodeficiency virus (HIV) lentivirus-mediated RNA interference (RNAi) to melanoma cells with the BRAF mutation (V599E) and overexpressed Skp-2 and found that the simultaneous suppression of these activated oncogenes resulted in the effective inhibition of in vitro cell growth and invasive ability of melanoma cells accompanied by the additional increase of p27Kip1. Our results suggest that gene therapy against melanoma with the enhanced MAPK and ubiquitin-proteasomal pathways could be a specific and effective therapeutic strategy for cancers.

AB - p27Kip1 that regulates the G1/S transition of cell cycle and inhibits Rho A signaling is frequently lost in several cancers leading to the deregulation of cell growth and cell motility. Mitogen-activated protein kinases (MAPK) regulate the export of p27Kip1 from nucleus to cytoplasm, followed by the degradation with proteases. Skp-2, a subunit of an SCF ubiquitin-protein ligase complex responsible for the ubiquitination of p27 Kip1, is upregulated frequently in several cancers, leading to the decrease of p27Kip1. We applied human immunodeficiency virus (HIV) lentivirus-mediated RNA interference (RNAi) to melanoma cells with the BRAF mutation (V599E) and overexpressed Skp-2 and found that the simultaneous suppression of these activated oncogenes resulted in the effective inhibition of in vitro cell growth and invasive ability of melanoma cells accompanied by the additional increase of p27Kip1. Our results suggest that gene therapy against melanoma with the enhanced MAPK and ubiquitin-proteasomal pathways could be a specific and effective therapeutic strategy for cancers.

KW - BRAF

KW - lentivirus

KW - p27

KW - RNA interference

KW - Skp-2

UR - http://www.scopus.com/inward/record.url?scp=28844433551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28844433551&partnerID=8YFLogxK

U2 - 10.1002/ijc.21286

DO - 10.1002/ijc.21286

M3 - Article

C2 - 16052531

AN - SCOPUS:28844433551

VL - 118

SP - 472

EP - 476

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 2

ER -